Clinical trial

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis…

NCT00349024 · Children's Cancer and Leukaemia Group, Other · Unknown status

Key facts

NCT number NCT00349024
Title Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
Official title Efficacy of Gelclair™ in Reducing the Pain of Oral Mucositis in Children and Young People With Cancer (SC 2005 07)
Lead sponsor Children's Cancer and Leukaemia Group, Other
Status Unknown status
Study type Interventional
Conditions Brain and Central Nervous System Tumors, Chordoma, Kidney Cancer, Leukemia, Lymphoma, Mucositis, Neuroblastoma, Pain, Sarcoma, Unspecified Childhood Solid Tumor and 1 more
Intervention type Drug
Interventions polyvinylpyrrolidone-sodium hyaluronate gel
Enrollment 50
Start date Jul 1, 2005
Primary completion Dec 1, 2009
First posted Jul 6, 2006
Last update posted Sep 20, 2013
Countries Ireland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies